High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome.

High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Abstract Text:

The metabolic syndrome (MetS) is associated with an increased incidence of diabetes and coronary heart disease. Postprandial lipemia is a prominent feature of dyslipidemia in both type 2 diabetes mellitus and MetS and is also associated with coronary heart disease. Oxidative stress and inflammation are pivotal in all stages of atherosclerosis; however, there is a paucity of data on postprandial oxidative stress and inflammation in subjects with MetS. Thus, the primary aim of this study was to compare the postprandial effects of an energy-dense, high-fat, fast-food-style (FFS) meal with an American Heart Association (AHA)-recommended heart-healthy meal on biomarkers of oxidative stress and inflammation in subjects with MetS. A total of 11 subjects with MetS completed the study. Glucose levels were significantly increased 2 hours after both FFS and AHA diets (P < .0001), and high-density lipoprotein cholesterol levels significantly decreased in FFS diet but not in the AHA diet (P for interaction < .05). Total triglyceride levels significantly increased postprandially only in the FFS meal but not in the AHA meal (P for interaction = .03). Plasma thiobarbituric acid reactive substances and malondialdehyde + hydroxynonenal increased significantly with time in both dietary groups, and the postprandial increase was greater in the FFS diet compared to the AHA diet (P < .0005). Serum high-sensitivity C-reactive protein, interleukin 6, and tumor necrosis factor levels did not change with time or dietary treatment. The postprandial increase in interleukin 1b was significantly higher with the FFS meal, thus resulting in significant differences between both treatments (P for interaction = .03). Thus, in subjects with MetS, consumption of an energy-dense, fatty meal (FFS breakfast) results in increased postprandial oxidative stress compared to a heart-healthy meal (AHA).

High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Metabolism: clinical and experimental

VOLUME: 57

Page Numbers: 867-70

Journal Abbreviation: Metab. Clin. Exp.

ISSN: 0026-0495

DAY: 26

MONTH: Jun

YEAR: 2008

High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 375267

High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome.

AFFILIATION: Laboratory for Atherosclerosis and Metabolic Research, UC Davis Medical Center, Sacramento,CA 95817, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Metabolism

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome Related Publications

• A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stress.
• Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop.
• C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling.
• CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers.
• Contemporary scientific insights: role of biomarkers of inflammation in cardiovascular disease/atherosclerosis.
• Detection by immunofixation of M proteins in hypogammaglobulinemic patients with normal serum protein electrophoresis results.
• Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome.
• Editor's Perspective on Metabolic Syndrome for 2008.
• Editorial.
• Effect of high-dose {alpha}-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease.
• Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome.
• High-dose alpha-tocopherol therapy does not affect HDL subfractions in patients with coronary artery disease on statin therapy.
• High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome.
• Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats.
• Increased Toll-Like Receptor (TLR) 2 and TLR4 Expression in Monocytes from Patients with Type 1 Diabetes: Further Evidence of a Proinflammatory State.
• Oxidative stress and atherosclerosis.
• RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus.
• Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome.
• Simvastatin reduces circulating plasminogen activator inhibitor 1 activity in volunteers with the metabolic syndrome.
• Statins and biomarkers of inflammation.
• The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells.
• The effect of weight loss and dietary fatty acids on inflammation.
• Validation of the circulating monocyte being representative of the cholesterol-loaded macrophage: biomediator activity.